Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.

Saglam, Esra; YÜCEL, SERAP; Balik, Emre; Saglam, Sezer; Asoglu, Oktar; YAMANER, Sumer; Bugra, Dursun; Oral, Ethem; Kizir, Ahmet; Kapran, Yersu; Sakar, Burak; Akyuz, Ali; Gulluoglu, Mine

doi:10.1007/s00432-014-1816-y

Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.

Saglam E. K., YÜCEL S., Balik E., Saglam S., Asoglu O., YAMANER S., ...Daha Fazla

Journal of cancer research and clinical oncology, cilt.141, sa.2, ss.361-7, 2015 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 141 Sayı: 2
Basım Tarihi: 2015
Doi Numarası: 10.1007/s00432-014-1816-y
Dergi Adı: Journal of cancer research and clinical oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.361-7
Anahtar Kelimeler: Adjuvant therapy, Chemoradiotherapy, Gastric cancer, D2 resection, PHASE-III TRIAL, NODAL DISSECTION, STOMACH-CANCER, CHEMOTHERAPY, ADENOCARCINOMA, RADIOTHERAPY, PATTERNS, SURGERY, CAPECITABINE, GASTRECTOMY
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Previous studies demonstrated survival benefits in association with the addition of chemoradiotherapy after surgery in gastric cancer. This study aimed to examine the efficacy in terms of loco-regional control and survival and safety of 5-FU-based adjuvant chemoradiotherapy after D2 curative surgery.